Test Price
600 AED✅ Home Collection Available
Hemophilia Panel (Factor VIII, IX & von Willebrand) in Dubai & UAE
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Hemophilia Panel is a comprehensive coagulation assessment evaluating factor VIII, factor IX, and von Willebrand factor to diagnose hemophilia and related bleeding disorders. This test is critical for patients with unexplained bleeding, family history, or pre-surgical evaluation, delivering precise results compliant with DHA guidelines.
| Feature | Our Hemophilia Panel | Basic Coagulation Screen |
|---|---|---|
| Methodology | Automated Coagulation Analyzer with Photo-optical & Electromechanical Clot Detection | Basic PT/aPTT only |
| Parameters | Factor VIII, IX, von Willebrand Factor, comprehensive panel | Limited to clotting times |
| Turnaround Time | Sample Wed/Sat by 9 am; Report Fri/Tue | 24–48 hours |
| Home Collection | VIP Mobile Phlebotomy with cold chain | May not include cold chain |
| Regulatory Compliance | DHA Licensed (Facility: 1143) & ISO 9001:2015 | Variable |
Physician Insight & Safety Protocols
Dr. Ajay Singh, General Practitioner (DHA ID: 36234132), recommends: "The Hemophilia Panel is a vital diagnostic tool for assessing bleeding disorders. However, a proper diagnosis requires correlation with clinical bleeding history, physical findings, and possibly genetic testing. Never adjust treatment based solely on a single laboratory result."
Safety, Preparation & Medication Advisory
Preparation Protocol: Overnight fasting is preferred. A duly filled Coagulation Requisition Form (Form 15) is mandatory. Sample collection requires 3 mL whole blood in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion and transport to the lab within 4 hours. If transport is delayed, prepare platelet-poor plasma (PPP) within 1 hour.
Medication Advisory: It is recommended that the patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect results. Discontinuation should be with prior consent of the treating Physician.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Active major bleeding, recent major surgery, known severe thrombocytopenia, or inability to provide informed consent.
- ER Red Flags: Sudden onset of severe bleeding, swelling at puncture site, difficulty breathing, or chest pain after blood collection. Seek immediate medical attention.
Patient FAQ & Clinical Guidance
1. What does the Hemophilia Panel test for?
This panel measures factor VIII, factor IX, and von Willebrand factor to diagnose hemophilia A, B, and von Willebrand disease. It also includes global coagulation assays to screen for abnormalities in the clotting cascade.
2. Why is overnight fasting required before the test?
Overnight fasting ensures accurate results by eliminating lipemic interference that can affect clot detection. High lipid levels in the blood after meals may falsely prolong clotting times.
3. How should I prepare for home blood collection?
Ensure you have fasted overnight, complete the Coagulation Requisition Form 15, and have your Emirates ID ready. Do not take heparin for 1 day or oral anticoagulants for 7 days unless approved by your physician.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Our clinical testing safety and patient consent protocols adhere strictly to Federal Decree-Law No. 4 of 2016 on Medical Liability.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). DHA Facility License: 1143.
Clinical & Logistical Metadata
| Test Name | Hemophilia Panel (Factor VIII, IX, vWF) |
| Price (AED) | 600 AED |
| Turnaround Time | Sample Wed/Sat by 9 am; Report Fri/Tue |
| Sample Type / Matrix | Whole Blood (Sodium Citrate) |
| Methodology Used | Automated Coagulation Analyzer with Photo-optical & Electromechanical Clot Detection |
| ICD-10-CM Code | D66, D67, D68.0 |
| LOINC Code | 6300-4 |
| DHA Facility License & Laboratory Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | License: 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians